Author

C. Foster

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 5 Evolutionary Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 3 Research Focus:cell type annotation· 3 Approach:experimental assay· 3 Approach:statistical model· 3 Research Focus:differential expression· 2 Organism:human· 2 Organism:mouse· 2 Assay:proteomics· 2

Frequent Co-Authors

B. G. Neel· 2 shared C. Borga· 2 shared H. Ran· 2 shared J. K. Frazer· 2 shared S. Iyer· 2 shared A. Babbage· 1 shared A. Bamford· 1 shared A. Butler· 1 shared

Activity by Year

2018-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

B. G. Neel

Mutual co-authors in cluster

Author profile →

7 papers

Recent·Most cited

Novel Methylation Markers in a Prostate Cancer Cohort are Associated with Disease Development and Relapse

R. P. Lach, S. Pita, W.-K. Leung, A. Babbage, S. Merson, S. Hawkins, H. Luxton, J. Kay, H. C. Whitaker, D. J. Woodcock, V. Haberland, Z. Kote-Jarai, T. Milne-Clark, K. O'Neill, T. Brendler-Spaeth, , A. G. Lynch

The paper identifies novel methylation markers in a prostate cancer cohort associated with disease development and relapse, showing their predictive power for recurrence.

bioRxiv · Aug 27, 2026 · PreprintCancer Biology

Spatial and Temporal Origin of The Third SARS-Cov-2 Outbreak in Taiwan

J.-H. Tai, Y. K. Low, S. C.-L. Wang, H.-F. Lin, T.-Y. Wang, Y.-Y. Lin, C. Foster, S. J. van Hal, Y.-Y. Lai, S.-H. Yeh, S.-Y. Chang, P.-J. Chen, S.-M. Chaw

This study identifies the third SARS-CoV-2 outbreak in Taiwan as originating from a European lineage introduced in February 2021, not from the US as previously thought.

bioRxiv · Jul 4, 2022 · PreprintEvolutionary Biology

Determinants of precocious B-cell aging in European adolescences living with perinatally acquired HIV-1 after over 10 years of suppressive therapy

A. Ruggiero, G. R. Pascucci, N. Cotugno, S. Dominguez-Rodriguez, R. Stefano, A. Tagarro Garcia, P. Rojo, C. Foster, A. Bamford, A. De Rossi, E. Nastouli, K. Nigel, M. Elena, B. Fatou, K. K. Smolen, , included in the manuscript

This study identifies factors associated with precocious B-cell aging in adolescents with perinatally acquired HIV on long-term suppressive therapy, linking them to immune dysfunction and reduced vaccine response.

bioRxiv · Nov 11, 2021 · PreprintImmunology

SHP2 Inhibition Abrogates Adaptive Resistance to KRASG12C-Inhibition and Remodels the Tumor Microenvironment of KRAS-Mutant Tumors

C. Fedele, S. Li, K. W. Teng, C. Foster, D. Peng, H. Ran, P. Mita, M. Geer, T. Hattori, A. Koide, Y. Wang, K. H. Tang, J. Leinwand, W. Wang, B. Diskin, , B. G. Neel

This study shows that combining SHP2 inhibitors with KRASG12C inhibitors enhances efficacy in PDAC and NSCLC by overcoming resistance and remodeling the tumor microenvironment.

bioRxiv · May 30, 2020Cancer Biology

Genetically Defined, Syngeneic Organoid Platform for Developing Combination Therapies for Ovarian Cancer

B. G. Neel, s. zhang, S. Iyer, H. Ran, W. wei, C. Foster, R. A. Weinberg

This paper develops a genetically defined, syngeneic organoid platform for ovarian cancer to evaluate combination therapies and finds genotype-specific responses to immunotherapy and chemotherapy.

bioRxiv · Apr 6, 2020Cancer Biology

Molecularly distinct models of zebrafish Myc-induced B cell leukemia

C. Borga, C. Foster, S. Iyer, S. Garcia, D. Langenau, J. K. Frazer

The paper compares two zebrafish B cell leukemia models driven by murine or human c-MYC, finding distinct lineage origins and molecular pathway signatures.

bioRxiv · Nov 6, 2018Cancer Biology

Simultaneous B and T cell acute lymphoblastic leukemias in zebrafish driven by transgenic MYC: implications for oncogenesis and lymphopoiesis

C. Borga, G. Park, C. Foster, J. Burroughs-Garcia, M. Marchesin, S. T. Ahmed, S. Bresolin, L. Batchelor, T. Scordino, R. R. Miles, G. te Kronnie, J. L. Regens, J. K. Frazer

This paper establishes the first zebrafish pre-B ALL model driven by human MYC, which also develops T-ALL, revealing differences in leukemogenesis and offering therapeutic insights.

bioRxiv · Mar 13, 2018Cancer Biology